Lifetime Overproduction of Circulating Angiotensin-(1-7) Attenuates Deoxycorticosterone Acetate-Salt Hypertension-Induced Cardiac Dysfunction and Remodeling


Autoria(s): SANTIAGO, Nivia M.; GUIMARAES, Priscila S.; SIRVENTE, Raquel A.; OLIVEIRA, Laser A. M.; IRIGOYEN, Maria C.; SANTOS, Robson A. S.; CAMPAGNOLE-SANTOS, Maria J.
Contribuinte(s)

UNIVERSIDADE DE SÃO PAULO

Data(s)

19/10/2012

19/10/2012

2010

Resumo

We evaluated the development of arterial hypertension, cardiac function, and collagen deposition, as well as the level of components of the renin-angiotensin system in the heart of transgenic rats that overexpress an angiotensin (Ang)-(1-7)-producing fusion protein, TGR(A1-7)3292 (TG), which induces a lifetime increase in circulating levels of this peptide. After 30 days of the induction of the deoxycorticosterone acetate (DOCA)-salt hypertension model, DOCA-TG rats were hypertensive but presented a lower systolic arterial pressure in comparison with DOCA-Sprague-Dawley (SD) rats. In contrast to DOCA-SD rats that presented left ventricle (LV) hypertrophy and diastolic dysfunction, DOCA-TG rats did not develop cardiac hypertrophy or changes in ventricular function. In addition, DOCA-TG rats showed attenuation in mRNA expression for collagen type I and III compared with the increased levels of DOCA-SD rats. Ang II plasma and LV levels were reduced in SD and TG hypertensive rats in comparison with normotensive animals. DOCA-TG rats presented a reduction in plasma Ang-(1-7) levels; however, there was a great increase in Ang-(1-7) (approximate to 3-fold) accompanied by a decrease in mRNA expression of both angiotensin-converting enzyme and angiotensin-converting enzyme 2 in the LV. The mRNA expression of Mas and Ang II type 1 receptors in the LV was not significantly changed in DOCA-SD or DOCA-TG rats. This study showed that TG rats with increased circulating levels of Ang-(1-7) are protected against cardiac dysfunction and fibrosis and also present an attenuated increase in blood pressure after DOCA-salt hypertension. In addition, DOCA-TG rats showed an important local increase in Ang-(1-7) levels in the LV, which might have contributed to the attenuation of cardiac dysfunction and prefibrotic lesions. (Hypertension. 2010;55:889-896.)

CAPES Coordenacao de Aperfeicoamentode Pessoal de Nivel Superior

High Blood Pressure Council

CNPq Conselho Nacional de Desenvolvimento Cientifico e Tecnologico

Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)

CAPES Coordenação de Aperfeiçoamento de Pessoal de Nível Superior

Programa de Nucleos de Excelencia (PRONEX)

Instituto Nacional de Ciencia e Tecnologia (INCT)

Identificador

HYPERTENSION, v.55, n.4, p.889-U134, 2010

0194-911X

http://producao.usp.br/handle/BDPI/27214

10.1161/HYPERTENSIONAHA.110.149815

http://dx.doi.org/10.1161/HYPERTENSIONAHA.110.149815

Idioma(s)

eng

Publicador

LIPPINCOTT WILLIAMS & WILKINS

Relação

Hypertension

Direitos

restrictedAccess

Copyright LIPPINCOTT WILLIAMS & WILKINS

Palavras-Chave #angiotensin-(1-7) #cardiac remodeling #cardiac function #hypertension #FUSION PROTEIN #RECEPTOR MAS #MYOCARDIAL-INFARCTION #CONVERTING ENZYME-2 #MARKED CHANGES #HEART FUNCTION #II RECEPTORS #RATS #HYPERTROPHY #MICE #Peripheral Vascular Disease
Tipo

article

original article

publishedVersion